The marathon surgical session, conducted between 8 am and 5 pm, was led by Dr (prof) Santosh Kumar, with the procedures ...

ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...

A UK-led international clinical trial is recruiting 280 patients to see if the technique to remove cancerous cells could ...

Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...

Darts fans have just a few more hours to enter to win the opportunity to throw nine darts on stage at Alexandra Palace - with ...

Josh Rock’s World Championship hopes may be over, but the darts star has still managed to make an impact in another way at Alexandra Palace.

For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently ...

For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

Here are the top 5 stories from 2025 about the advancements in prostate, kidney, and bladder cancers.

This week we have selected a recent article from The Conversation contributed by Dr Francesco Crea, a clinician and research ...